ArticleScience advances2025

Mendelian randomization study implicates inflammaging biomarkers in retinal vasculature, cardiovascular diseases, and longevity.

Ana Villaplana-Velasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.